{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:04:12Z","timestamp":1775581452690,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI13\/00364"],"award-info":[{"award-number":["FIS PI13\/00364"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00471"],"award-info":[{"award-number":["PI16\/00471"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBERDEM (CB07\/08\/0016)"],"award-info":[{"award-number":["CIBERDEM (CB07\/08\/0016)"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FEDER funds"},{"name":"Spanish Society of Diabetes","award":["III SED aids to projects of clinical"],"award-info":[{"award-number":["III SED aids to projects of clinical"]}]},{"name":"Spanish Society of Diabetes","award":["basic research directed by young researchers 2012"],"award-info":[{"award-number":["basic research directed by young researchers 2012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12933-018-0794-9","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:18:12Z","timestamp":1544141892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-4697","authenticated-orcid":false,"given":"Cristina","family":"Colom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vilad\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"P\u00e9rez-Cuellar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Leta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Rivas-Urbina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Ord\u00f3\u00f1ez-Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"S\u00e1nchez-Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"794_CR1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1365-2265.2008.03411.x","volume":"70","author":"C-P Wang","year":"2009","unstructured":"Wang C-P, Hsu H-L, Hung W-C, Yu T-H, Chen Y-H, Chiu C-A, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf). 2009;70:876\u201382.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"794_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/met.2013.0107","volume":"12","author":"SW Rabkin","year":"2014","unstructured":"Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12:31\u201342.","journal-title":"Metab Syndr Relat Disord."},{"key":"794_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12944-018-0856-8","volume":"17","author":"O Gruzdeva","year":"2018","unstructured":"Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O. Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018;17:218.","journal-title":"Lipids Health Dis."},{"key":"794_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1536\/ihj.13-303","volume":"55","author":"S-H Kim","year":"2014","unstructured":"Kim S-H, Chung J-H, Kwon B-J, Song S-W, Choi W-S. The associations of epicardial adipose tissue with coronary artery disease and coronary atherosclerosis. Int Heart J. 2014;55:197\u2013203.","journal-title":"Int Heart J."},{"key":"794_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2010.01.028","volume":"211","author":"B Verg\u00e8s","year":"2010","unstructured":"Verg\u00e8s B. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Atherosclerosis. 2010;211:353\u201360.","journal-title":"Atherosclerosis."},{"key":"794_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11892-008-0013-2","volume":"8","author":"JA Farmer","year":"2008","unstructured":"Farmer JA. Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Diab Rep. 2008;8:71\u20137.","journal-title":"Curr Diab Rep."},{"key":"794_CR7","first-page":"153","volume":"41","author":"R Namiri-Kalantari","year":"2015","unstructured":"Namiri-Kalantari R, Gao F, Chattopadhyay A, Wheeler AA, Navab KD, Farias-Eisner R, et al. The dual nature of HDL: anti-Inflammatory and pro-Inflammatory. BioFact Oxf Engl. 2015;41:153\u20139.","journal-title":"BioFact Oxf Engl."},{"key":"794_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","volume":"224","author":"A Kontush","year":"2015","unstructured":"Kontush A, Lindahl M, Lhomme M, Calabresi L, Chapman MJ, Davidson WS. Structure of HDL: particle subclasses and molecular components. Handb Exp Pharmacol. 2015;224:3\u201351.","journal-title":"Handb Exp Pharmacol"},{"key":"794_CR9","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","volume":"371","author":"M Lind","year":"2014","unstructured":"Lind M, Svensson A-M, Kosiborod M, Gudbj\u00f6rnsdottir S, Pivodic A, Wedel H, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972\u201382.","journal-title":"N Engl J Med"},{"key":"794_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1210\/jc.2009-1756","volume":"95","author":"KJ Nadeau","year":"2010","unstructured":"Nadeau KJ, Regensteiner JG, Bauer TA, Brown MS, Dorosz JL, Hull A, et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab. 2010;95:513\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"794_CR11","doi-asserted-by":"publisher","first-page":"e0159958","DOI":"10.1371\/journal.pone.0159958","volume":"11","author":"S Darabian","year":"2016","unstructured":"Darabian S, Backlund J-YC, Cleary PA, Sheidaee N, Bebu I, Lachin JM, et al. Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT\/EDIC. A pilot study. PLoS ONE. 2016;11:e0159958.","journal-title":"PLoS ONE."},{"key":"794_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jcct.2008.08.008","volume":"2","author":"JH Nichols","year":"2008","unstructured":"Nichols JH, Samy B, Nasir K, Fox CS, Schulze PC, Bamberg F, et al. Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study. J Cardiovasc Comput Tomogr. 2008;2:288\u201395.","journal-title":"J Cardiovasc Comput Tomogr."},{"key":"794_CR13","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1001\/archinte.160.18.2756","volume":"160","author":"A P\u00e9rez","year":"2000","unstructured":"P\u00e9rez A, W\u00e4gner AM, Carreras G, Gim\u00e9nez G, S\u00e1nchez-Quesada JL, Rigla M, et al. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control. Arch Intern Med. 2000;160:2756\u201362.","journal-title":"Arch Intern Med"},{"key":"794_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2017.10.018","volume":"267","author":"S Ganjali","year":"2017","unstructured":"Ganjali S, Dallinga-Thie GM, Simental-Mend\u00eda LE, Banach M, Pirro M, Sahebkar A. HDL functionality in type 1 diabetes. Atherosclerosis. 2017;267:99\u2013109.","journal-title":"Atherosclerosis."},{"issue":"1","key":"794_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12933-017-0570-2","volume":"16","author":"M Heier","year":"2017","unstructured":"Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, et al. Reduced HDL function in children and young adults with type 1 diabetes. Cardiovasc Diabetol. 2017;16(1):85.","journal-title":"Cardiovasc Diabetol."},{"key":"794_CR16","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0300-8932(05)74065-3","volume":"58","author":"P Zimmet","year":"2005","unstructured":"Zimmet P, Alberti KG, Serrano R\u00edos M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol. 2005;58:1371\u20136.","journal-title":"Rev Esp Cardiol"},{"key":"794_CR17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/CIRCULATIONAHA.105.168237","volume":"112","author":"MJ Budoff","year":"2005","unstructured":"Budoff MJ, Cohen MC, Garcia MJ, Hodgson JM, Hundley WG, Lima JAC, et al. ACCF\/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. Circulation. 2005;112:598\u2013617.","journal-title":"Circulation"},{"key":"794_CR18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-2275(20)30111-5","volume":"43","author":"JL S\u00e1nchez-Quesada","year":"2002","unstructured":"S\u00e1nchez-Quesada JL, Ben\u00edtez S, Otal C, Franco M, Blanco-Vaca F, Ord\u00f3\u00f1ez-Llanos J. Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects. J Lipid Res. 2002;43:699\u2013705.","journal-title":"J Lipid Res"},{"key":"794_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.RES.0000146031.94850.5f","volume":"95","author":"V Ribas","year":"2004","unstructured":"Ribas V, S\u00e1nchez-Quesada JL, Ant\u00f3n R, Camacho M, Julve J, Escol\u00e0-Gil JC, et al. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ Res. 2004;95:789\u201397.","journal-title":"Circ Res"},{"key":"794_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/01.CIR.0000072791.40232.8F","volume":"108","author":"S Ben\u00edtez","year":"2003","unstructured":"Ben\u00edtez S, S\u00e1nchez-Quesada JL, Ribas V, Jorba O, Blanco-Vaca F, Gonz\u00e1lez-Sastre F, et al. Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction. Circulation. 2003;108:92\u20136.","journal-title":"Circulation"},{"key":"794_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1475-2840-12-112","volume":"12","author":"JL S\u00e1nchez-Quesada","year":"2013","unstructured":"S\u00e1nchez-Quesada JL, Vinagre I, De Juan-Franco E, S\u00e1nchez-Hern\u00e1ndez J, Bonet-Marques R, Blanco-Vaca F, et al. Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes. Cardiovasc Diabetol. 2013;12:112.","journal-title":"Cardiovasc Diabetol."},{"key":"794_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-017-0528-4","volume":"16","author":"N Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez N, Moreno-Villegas Z, Gonz\u00e1lez-Bris A, Egido J, Lorenzo \u00d3. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16:44.","journal-title":"Cardiovasc Diabetol."},{"key":"794_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1161\/ATVBAHA.108.180653","volume":"29","author":"M Greif","year":"2009","unstructured":"Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:781\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"794_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2009.08.032","volume":"209","author":"D Dey","year":"2010","unstructured":"Dey D, Wong ND, Tamarappoo B, Nakazato R, Gransar H, Cheng VY, et al. Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and metabolic syndrome. Atherosclerosis. 2010;209:136\u201341.","journal-title":"Atherosclerosis."},{"key":"794_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/ehjci\/jes024","volume":"13","author":"MO Versteylen","year":"2012","unstructured":"Versteylen MO, Takx RAP, Joosen IAPG, Nelemans PJ, Das M, Crijns HJGM, et al. Epicardial adipose tissue volume as a predictor for coronary artery disease in diabetic, impaired fasting glucose, and non-diabetic patients presenting with chest pain. Eur Heart J Cardiovasc Imaging. 2012;13:517\u201323.","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"794_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijcard.2010.12.085","volume":"158","author":"N Bettencourt","year":"2012","unstructured":"Bettencourt N, Toschke AM, Leite D, Rocha J, Carvalho M, Sampaio F, et al. Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol. 2012;158:26\u201332.","journal-title":"Int J Cardiol"},{"key":"794_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/14017431.2014.942872","volume":"48","author":"M Monti","year":"2014","unstructured":"Monti M, Monti A, Murdolo G, Di Renzi P, Pirro MR, Borgognoni F, et al. Correlation between epicardial fat and cigarette smoking: CT imaging in patients with metabolic syndrome. Scand Cardiovasc J. 2014;48:317\u201322.","journal-title":"Scand Cardiovasc J."},{"key":"794_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12933-018-0735-7","volume":"17","author":"DH Cho","year":"2018","unstructured":"Cho DH, Joo HJ, Kim MN, Lim DS, Shim WJ, Park SM. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome. Cardiovasc Diabetol. 2018;17:95.","journal-title":"Cardiovasc Diabetol."},{"key":"794_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2010.09.037","volume":"91","author":"DP Momesso","year":"2011","unstructured":"Momesso DP, Bussade I, Epifanio MA, Schettino CDS, Russo LAT, Kupfer R. Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome. Diabetes Res Clin Pract. 2011;91:47\u201353.","journal-title":"Diabetes Res Clin Pract"},{"key":"794_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12020-011-9478-x","volume":"40","author":"D Yaz\u0131c\u0131","year":"2011","unstructured":"Yaz\u0131c\u0131 D, \u00d6zben B, Yavuz D, Deyneli O, Ayd\u0131n H, Tarcin \u00d6, et al. Epicardial adipose tissue thickness in type 1 diabetic patients. Endocrine. 2011;40:250\u20135.","journal-title":"Endocrine"},{"key":"794_CR31","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/echo.12960","volume":"32","author":"AN Aslan","year":"2015","unstructured":"Aslan AN, Kele\u015f T, Ayhan H, Kasapkara HA, Ak\u00e7ay M, Durmaz T, et al. The relationship between epicardial fat thickness and endothelial dysfunction in type I diabetes mellitus. Echocardiography. 2015;32:1745\u201353.","journal-title":"Echocardiography."},{"key":"794_CR32","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.amjcard.2011.07.031","volume":"108","author":"H Shmilovich","year":"2011","unstructured":"Shmilovich H, Dey D, Cheng VY, Rajani R, Nakazato R, Otaki Y, et al. Threshold for the upper normal limit of indexed epicardial fat volume: derivation in a healthy population and validation in an outcome-based study. Am J Cardiol. 2011;108:1680\u20135.","journal-title":"Am J Cardiol"},{"key":"794_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1161\/ATVBAHA.117.309493","volume":"37","author":"M Miller","year":"2017","unstructured":"Miller M. Apolipoprotein C-III: the small protein with sizeable vascular risk. Arterioscler Thromb Vasc Biol. 2017;37:1013\u20134.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"794_CR34","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","volume":"137","author":"MK Jensen","year":"2018","unstructured":"Jensen MK, Aroner SA, Mukamal KJ, Furtado JD, Post WS, Tsai MY, et al. High-density lipoprotein subspecies defined by presence of apolipoprotein C-III and incident coronary heart disease in four cohorts. Circulation. 2018;137:1364\u201373.","journal-title":"Circulation"},{"key":"794_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12944-015-0129-8","volume":"14","author":"X Xiong","year":"2015","unstructured":"Xiong X, Liu H, Hua L, Zhao H, Wang D, Li Y. The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it. Lipids Health Dis. 2015;14:127.","journal-title":"Lipids Health Dis."},{"key":"794_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","volume":"127","author":"M Riwanto","year":"2013","unstructured":"Riwanto M, Rohrer L, Roschitzki B, Besler C, Mocharla P, Mueller M, et al. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation. 2013;127:891\u2013904.","journal-title":"Circulation"},{"key":"794_CR37","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","volume":"102","author":"FM Sacks","year":"2000","unstructured":"Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, et al. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial. Circulation. 2000;102:1886\u201392.","journal-title":"Circulation"},{"key":"794_CR38","doi-asserted-by":"publisher","first-page":"14788","DOI":"10.1073\/pnas.93.25.14788","volume":"93","author":"W Weng","year":"1996","unstructured":"Weng W, Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci USA. 1996;93:14788\u201394.","journal-title":"Proc Natl Acad Sci USA."},{"key":"794_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1388-1981(00)00127-X","volume":"1488","author":"J Julve","year":"2000","unstructured":"Julve J, Escol\u00e0-Gil JC, Marzal-Casacuberta A, Ord\u00f3\u00f1ez-Llanos J, Gonz\u00e1lez-Sastre F, Blanco-Vaca F. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet. Biochim Biophys Acta. 2000;1488:233\u201344.","journal-title":"Biochim Biophys Acta"},{"key":"794_CR40","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/hc3601.095709","volume":"104","author":"FM Hooft van\u2019t","year":"2001","unstructured":"van\u2019t Hooft FM, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A. Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation. 2001;104:1223\u20138.","journal-title":"Circulation."},{"key":"794_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1476-511X-11-125","volume":"11","author":"A Perelas","year":"2012","unstructured":"Perelas A, Safarika V, Vlachos IS, Tzanetakou I, Korou L-M, Konstantopoulos P, et al. Correlation between mesenteric fat thickness and serum apolipoproteins in patients with peripheral arterial occlusive disease. Lipids Health Dis. 2012;11:125.","journal-title":"Lipids Health Dis."},{"key":"794_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2337\/diabetes.50.3.643","volume":"50","author":"LW Castellani","year":"2001","unstructured":"Castellani LW, Goto AM, Lusis AJ. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes. 2001;50:643\u201351.","journal-title":"Diabetes"},{"key":"794_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1479164109346358","volume":"7","author":"RG Miller","year":"2010","unstructured":"Miller RG, Costacou T, Orchard TJ. Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria. Diab Vasc Dis Res. 2010;7:47\u201355.","journal-title":"Diab Vasc Dis Res."},{"key":"794_CR44","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jacl.2016.01.001","volume":"10","author":"JL Jarvie","year":"2016","unstructured":"Jarvie JL, Wang H, Kinney GL, Snell-Bergeon J, Hokanson JE, Eckel RH. Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in\u00a0type 1 diabetes. J Clin Lipidol. 2016;10:577\u201386.","journal-title":"J Clin Lipidol."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-018-0794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-018-0794-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-018-0794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:03:26Z","timestamp":1775297006000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-018-0794-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1186\/s12933-018-0794-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"21 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"156"}}